These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 31053531)

  • 1. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
    Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
    Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of STN-DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson's disease.
    Luo G; Shi X; Jiang L; Wu L; Yi C; Xian W; Liu Y; Wen F; Qian H; Chen J; Fu X; Liu J; Zhang X; Chen L
    Brain Behav; 2023 Aug; 13(8):e3172. PubMed ID: 37459244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease.
    Hilker R; Voges J; Weisenbach S; Kalbe E; Burghaus L; Ghaemi M; Lehrke R; Koulousakis A; Herholz K; Sturm V; Heiss WD
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):7-16. PubMed ID: 14688612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study.
    Le Jeune F; Péron J; Grandjean D; Drapier S; Haegelen C; Garin E; Millet B; Vérin M
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1512-20. PubMed ID: 20349231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation.
    Cao C; Zhang H; Li D; Zhan S; Zhang J; Zhang X; Zuo C; Sun B
    Stereotact Funct Neurosurg; 2017; 95(2):93-101. PubMed ID: 28259880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.
    Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S
    Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson's disease: A pilot study of DATSCAN for subthalamic deep brain stimulation.
    Nakajima A; Shimo Y; Sekimoto S; Kamagata K; Jo T; Oyama G; Umemura A; Hattori N
    J Neurol Sci; 2018 Feb; 385():134-139. PubMed ID: 29406893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subthalamic deep brain stimulation on striatal metabolic connectivity in a rat hemiparkinsonian model.
    Apetz N; Kordys E; Simon M; Mang B; Aswendt M; Wiedermann D; Neumaier B; Drzezga A; Timmermann L; Endepols H
    Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31064773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans.
    Hilker R; Voges J; Ghaemi M; Lehrke R; Rudolf J; Koulousakis A; Herholz K; Wienhard K; Sturm V; Heiss WD
    Mov Disord; 2003 Jan; 18(1):41-8. PubMed ID: 12518299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease.
    Chen HM; Sha ZQ; Ma HZ; He Y; Feng T
    CNS Neurosci Ther; 2018 Feb; 24(2):135-143. PubMed ID: 29222835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPECT and PET analysis of subthalamic stimulation in Parkinson's disease: analysis using a manual segmentation.
    Haegelen C; García-Lorenzo D; Le Jeune F; Péron J; Gibaud B; Riffaud L; Brassier G; Barillot C; Vérin M; Morandi X
    J Neurol; 2010 Mar; 257(3):375-82. PubMed ID: 19774437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic nucleus stimulation effects on single and combined task performance in Parkinson's disease patients: a PET study.
    Atkinson-Clement C; Maillet A; LeBars D; Lavenne F; Redouté J; Krainik A; Pollak P; Thobois S; Pinto S
    Brain Imaging Behav; 2017 Aug; 11(4):1139-1153. PubMed ID: 27704407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation.
    Herzog J; Weiss PH; Assmus A; Wefer B; Seif C; Braun PM; Pinsker MO; Herzog H; Volkmann J; Deuschl G; Fink GR
    Brain; 2008 Jan; 131(Pt 1):132-45. PubMed ID: 17977862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebello-striatal interaction mediates effects of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Hanssen H; Steinhardt J; Münchau A; Al-Zubaidi A; Tzvi E; Heldmann M; Schramm P; Neumann A; Rasche D; Saryyeva A; Voges J; Galazky I; Büntjen L; Heinze HJ; Krauss JK; Tronnier V; Münte TF; Brüggemann N
    Parkinsonism Relat Disord; 2019 Oct; 67():99-104. PubMed ID: 31494048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus deep brain stimulation induces functional deficits in norepinephrinergic neurotransmission in a Parkinson's disease model.
    Statz M; Weber H; Weis F; Kober M; Bathel H; Plocksties F; van Rienen U; Timmermann D; Storch A; Fauser M
    Brain Res; 2024 Oct; 1841():149128. PubMed ID: 39053685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Langner-Lemercier S; Drapier S; Naudet F; Le Clanche N; Houvenaghel JF; Sauleau P; Jannin P; Haegelen C; Le Jeune F; Vérin M
    J Neurol; 2015; 262(4):881-9. PubMed ID: 25634679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cerebral activity changes induced by subthalamic nucleus stimulation in advanced Parkinson's disease: a prospective case-control study.
    Cilia R; Marotta G; Landi A; Isaias IU; Mariani CB; Vergani F; Benti R; Sganzerla E; Pezzoli G; Antonini A
    Clin Neurol Neurosurg; 2009 Feb; 111(2):140-6. PubMed ID: 18995954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A network analysis of ¹⁵O-H₂O PET reveals deep brain stimulation effects on brain network of Parkinson's disease.
    Park HJ; Park B; Kim HY; Oh MK; Kim JI; Yoon M; Lee JD; Chang JW
    Yonsei Med J; 2015 May; 56(3):726-36. PubMed ID: 25837179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.